ENTHD1
gene geneOn this page
Also known as FLJ25421
Summary
ENTHD1 (ENTH domain containing 1, HGNC:26352) is a protein-coding gene on chromosome 22q13.1, encoding ENTH domain-containing protein 1 (Q8IYW4).
Predicted to enable clathrin binding activity and phospholipid binding activity. Predicted to be involved in endocytosis. Predicted to be part of clathrin vesicle coat. Predicted to be active in endosome and plasma membrane.
Source: NCBI Gene 150350 — RefSeq curated summary.
At a glance
- GWAS associations: 6
- Clinical variants (ClinVar): 89 total
- MANE Select transcript:
NM_152512
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26352 |
| Approved symbol | ENTHD1 |
| Name | ENTH domain containing 1 |
| Location | 22q13.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ25421 |
| Ensembl gene | ENSG00000176177 |
| Ensembl biotype | protein_coding |
| Entrez | 150350 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 1 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000325157, ENST00000490326
RefSeq mRNA: 1 — MANE Select: NM_152512
NM_152512
CCDS: CCDS13998
Canonical transcript exons
ENST00000325157 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001247423 | 39765223 | 39765609 |
| ENSE00001247429 | 39820993 | 39821113 |
| ENSE00001247443 | 39743044 | 39744283 |
| ENSE00001247451 | 39835840 | 39835958 |
| ENSE00001290271 | 39887400 | 39887903 |
| ENSE00001325790 | 39861765 | 39862007 |
| ENSE00001425670 | 39893695 | 39893760 |
Expression profiles
Bgee: expression breadth broad, 50 present calls, max score 88.31.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0113 / max 8.5706, expressed in 4 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 194298 | 0.0096 | 4 |
| 194297 | 0.0017 | 1 |
Top tissues by expression
218 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 88.31 | gold quality |
| right testis | UBERON:0004534 | 74.18 | gold quality |
| left testis | UBERON:0004533 | 73.14 | gold quality |
| testis | UBERON:0000473 | 72.50 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 65.05 | gold quality |
| tibial nerve | UBERON:0001323 | 64.88 | gold quality |
| sperm | CL:0000019 | 61.68 | silver quality |
| lower lobe of lung | UBERON:0008949 | 55.40 | silver quality |
| lymph node | UBERON:0000029 | 54.41 | gold quality |
| adult organism | UBERON:0007023 | 52.61 | gold quality |
| vermiform appendix | UBERON:0001154 | 52.24 | gold quality |
| nucleus accumbens | UBERON:0001882 | 52.24 | gold quality |
| monocyte | CL:0000576 | 50.20 | gold quality |
| caecum | UBERON:0001153 | 49.52 | gold quality |
| leukocyte | CL:0000738 | 49.01 | silver quality |
| granulocyte | CL:0000094 | 44.91 | silver quality |
| gall bladder | UBERON:0002110 | 44.18 | silver quality |
| tonsil | UBERON:0002372 | 43.53 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| colonic epithelium | UBERON:0000397 | 42.30 | gold quality |
| visceral pleura | UBERON:0002401 | 42.29 | gold quality |
| vastus lateralis | UBERON:0001379 | 41.67 | gold quality |
| oviduct epithelium | UBERON:0004804 | 41.67 | gold quality |
| quadriceps femoris | UBERON:0001377 | 41.63 | gold quality |
| superficial temporal artery | UBERON:0001614 | 41.33 | gold quality |
| islet of Langerhans | UBERON:0000006 | 41.17 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 41.10 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 40.98 | gold quality |
| amniotic fluid | UBERON:0000173 | 40.69 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.74 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
35 targeting ENTHD1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4776-3P | 100.00 | 68.73 | 1340 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-4725-3P | 99.96 | 69.53 | 2520 |
| HSA-MIR-6780B-5P | 99.96 | 69.60 | 2562 |
| HSA-MIR-2110 | 99.96 | 66.68 | 1930 |
| HSA-MIR-9983-3P | 99.94 | 71.48 | 3631 |
| HSA-MIR-129-5P | 99.88 | 70.26 | 3273 |
| HSA-MIR-3121-3P | 99.82 | 71.96 | 3630 |
| HSA-MIR-204-5P | 99.79 | 71.62 | 2439 |
| HSA-MIR-211-5P | 99.79 | 71.65 | 2440 |
| HSA-MIR-548AJ-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-548F-5P | 99.78 | 71.02 | 3093 |
| HSA-MIR-548G-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-548X-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-4517 | 99.76 | 69.19 | 1867 |
| HSA-MIR-4645-3P | 99.76 | 69.33 | 993 |
| HSA-MIR-4755-5P | 99.71 | 70.34 | 2716 |
| HSA-MIR-5006-3P | 99.71 | 70.26 | 2728 |
| HSA-MIR-545-5P | 99.66 | 70.18 | 2308 |
| HSA-MIR-488-3P | 99.61 | 68.79 | 1731 |
| HSA-MIR-497-3P | 99.61 | 69.71 | 1990 |
| HSA-MIR-510-3P | 99.54 | 70.06 | 2965 |
| HSA-MIR-6832-3P | 99.52 | 70.44 | 1726 |
| HSA-MIR-4452 | 99.50 | 68.45 | 1493 |
| HSA-MIR-3182 | 99.40 | 68.15 | 2454 |
| HSA-MIR-1276 | 99.36 | 68.18 | 1642 |
| HSA-MIR-548L | 99.06 | 70.90 | 2560 |
| HSA-MIR-10524-5P | 99.05 | 66.08 | 963 |
| HSA-MIR-6830-5P | 99.01 | 68.73 | 1884 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Enthd1 | ENSMUSG00000050439 |
| rattus_norvegicus | Enthd1 | ENSRNOG00000025344 |
| drosophila_melanogaster | lqf | FBGN0028582 |
| caenorhabditis_elegans | WBGENE00001329 |
Paralogs (5): EPN3 (ENSG00000049283), EPN1 (ENSG00000063245), EPN2 (ENSG00000072134), CLINT1 (ENSG00000113282), MYCBPAP (ENSG00000136449)
Protein
Protein identifiers
ENTH domain-containing protein 1 — Q8IYW4 (reviewed: Q8IYW4)
Alternative names: Epsin-2B
All UniProt accessions (1): Q8IYW4
RefSeq proteins (1): NP_689725* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR008942 | ENTH_VHS | Homologous_superfamily |
| IPR013809 | ENTH | Domain |
Pfam: PF01417
UniProt features (4 total): chain 1, domain 1, coiled-coil region 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IYW4-F1 | 57.58 | 0.29 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 68 (showing top):
RNGTGGGC_UNKNOWN, GOBP_VESICLE_MEDIATED_TRANSPORT, ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP, GOCC_COATED_VESICLE, TCF11_01, GGGNNTTTCC_NFKB_Q6_01, GOCC_VESICLE_COAT, GOBP_IMPORT_INTO_CELL, GOBP_ENDOCYTOSIS, NKX3A_01, GOCC_CLATHRIN_COATED_VESICLE, GOCC_CLATHRIN_COAT, GOCC_CLATHRIN_VESICLE_COAT, chr22q13, GOCC_CLATHRIN_COATED_VESICLE_MEMBRANE
GO Biological Process (1): endocytosis (GO:0006897)
GO Molecular Function (3): phospholipid binding (GO:0005543), clathrin binding (GO:0030276), protein binding (GO:0005515)
GO Cellular Component (4): endosome (GO:0005768), plasma membrane (GO:0005886), clathrin vesicle coat (GO:0030125), cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| vesicle budding from membrane | 1 |
| membrane invagination | 1 |
| vesicle-mediated transport | 1 |
| import into cell | 1 |
| lipid binding | 1 |
| protein binding | 1 |
| binding | 1 |
| endomembrane system | 1 |
| cytoplasmic vesicle | 1 |
| membrane | 1 |
| cell periphery | 1 |
| clathrin coat | 1 |
| vesicle coat | 1 |
| clathrin-coated vesicle membrane | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
657 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ENTHD1 | S4R434 | S4R434 | 575 |
| ENTHD1 | ZNHIT2 | Q9UHR6 | 531 |
| ENTHD1 | KATNA1 | O75449 | 520 |
| ENTHD1 | PRDM10 | Q9NQV6 | 496 |
| ENTHD1 | TSGA10IP | Q3SY00 | 473 |
| ENTHD1 | SLITRK1 | Q96PX8 | 462 |
| ENTHD1 | KIF18A | Q8NI77 | 458 |
| ENTHD1 | FAXC | Q5TGI0 | 454 |
| ENTHD1 | HERC5 | Q9UII4 | 450 |
| ENTHD1 | LINC03042 | Q6ZUL3 | 431 |
| ENTHD1 | FSCN3 | Q9NQT6 | 427 |
| ENTHD1 | MEIOB | Q8N635 | 408 |
| ENTHD1 | CNPY2 | Q9Y2B0 | 402 |
| ENTHD1 | HUS1B | Q8NHY5 | 378 |
| ENTHD1 | DNAJC11 | Q9NVH1 | 373 |
IntAct
7 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ENTHD1 | SNAPIN | psi-mi:“MI:0915”(physical association) | 0.670 |
| SNAPIN | ENTHD1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| ENTHD1 | HADHA | psi-mi:“MI:0915”(physical association) | 0.400 |
| P | psi-mi:“MI:0914”(association) | 0.350 | |
| ENTHD1 | C1orf226 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (23): ENTHD1 (Two-hybrid), ENTHD1 (Proximity Label-MS), SNAPIN (Affinity Capture-MS), TRIOBP (Affinity Capture-MS), LRRC45 (Affinity Capture-MS), SASS6 (Affinity Capture-MS), KLC4 (Affinity Capture-MS), C1orf226 (Affinity Capture-MS), VPS53 (Affinity Capture-MS), SMTNL2 (Affinity Capture-MS), TXLNG (Affinity Capture-MS), CEP250 (Affinity Capture-MS), TXLNA (Affinity Capture-MS), CEP55 (Affinity Capture-MS), BLOC1S3 (Affinity Capture-MS)
ESM2 similar proteins: B0S6S9, B7ZUL2, D2HXI8, D3Z987, D3ZJ47, E1BC15, E1BFR5, O43303, P10242, P29352, P51957, P56715, Q06190, Q06BR1, Q0P5X5, Q1X8D7, Q3V089, Q49A88, Q5BQN8, Q5RCM2, Q5RD97, Q5SW75, Q5W0B1, Q5ZLE9, Q60DG4, Q62394, Q6KAQ7, Q6NRK3, Q6PJP8, Q6ZP01, Q6ZU52, Q6ZV73, Q76I76, Q80WQ8, Q86UW6, Q86V20, Q86XD8, Q8C0P0, Q8IYH5, Q8IYW4
Diamond homologs: A7Z035, O74423, O88339, O95208, P47160, P78813, Q05785, Q12518, Q14677, Q4V882, Q54EH1, Q67YI9, Q80VP1, Q8CHU3, Q8IYW4, Q8VY07, Q91W69, Q93YP4, Q99KN9, Q9H201, Q9Y6I3, Q9Z1Z3, Q07872
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
89 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 66 |
| Likely benign | 18 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2007 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 22:39821111:GTCC:G | acceptor_loss | 1.0000 |
| 22:39821114:C:A | acceptor_loss | 1.0000 |
| 22:39861804:T:TA | donor_gain | 1.0000 |
| 22:39876444:T:TA | donor_gain | 1.0000 |
| 22:39893689:TGTTA:T | donor_loss | 1.0000 |
| 22:39893690:GTTAC:G | donor_loss | 1.0000 |
| 22:39893691:TTACC:T | donor_loss | 1.0000 |
| 22:39893692:TACC:T | donor_loss | 1.0000 |
| 22:39893694:C:CA | donor_loss | 1.0000 |
| 22:39744238:A:C | acceptor_gain | 0.9900 |
| 22:39744284:C:CC | acceptor_gain | 0.9900 |
| 22:39782967:T:TC | acceptor_gain | 0.9900 |
| 22:39820988:TTTAC:T | donor_loss | 0.9900 |
| 22:39820989:TTAC:T | donor_loss | 0.9900 |
| 22:39820990:TAC:T | donor_loss | 0.9900 |
| 22:39820991:ACC:A | donor_loss | 0.9900 |
| 22:39820992:C:CG | donor_loss | 0.9900 |
| 22:39820992:CCT:C | donor_gain | 0.9900 |
| 22:39820994:TGC:T | donor_gain | 0.9900 |
| 22:39821016:T:TA | donor_gain | 0.9900 |
| 22:39821114:C:CC | acceptor_gain | 0.9900 |
| 22:39821118:C:CT | acceptor_gain | 0.9900 |
| 22:39821119:A:T | acceptor_gain | 0.9900 |
| 22:39835833:GACTT:G | donor_loss | 0.9900 |
| 22:39835834:ACTTA:A | donor_loss | 0.9900 |
| 22:39835835:CTTA:C | donor_loss | 0.9900 |
| 22:39835836:TTA:T | donor_loss | 0.9900 |
| 22:39835837:TACC:T | donor_loss | 0.9900 |
| 22:39835838:A:AT | donor_loss | 0.9900 |
| 22:39861763:A:AC | donor_gain | 0.9900 |
AlphaMissense
3998 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 22:39887679:C:G | A24P | 0.998 |
| 22:39887495:C:T | G85E | 0.997 |
| 22:39887507:A:G | L81P | 0.997 |
| 22:39887530:T:A | K73N | 0.997 |
| 22:39887530:T:G | K73N | 0.997 |
| 22:39887531:T:A | K73I | 0.997 |
| 22:39887519:A:G | L77P | 0.996 |
| 22:39887525:A:G | L75P | 0.996 |
| 22:39887547:A:G | W68R | 0.996 |
| 22:39887547:A:T | W68R | 0.996 |
| 22:39887532:T:C | K73E | 0.995 |
| 22:39861995:C:G | R121P | 0.994 |
| 22:39887495:C:A | G85V | 0.994 |
| 22:39887500:C:A | K83N | 0.994 |
| 22:39887500:C:G | K83N | 0.994 |
| 22:39887545:C:A | W68C | 0.994 |
| 22:39887545:C:G | W68C | 0.994 |
| 22:39887683:C:A | R22S | 0.994 |
| 22:39887683:C:G | R22S | 0.994 |
| 22:39887431:A:C | F106L | 0.993 |
| 22:39887431:A:T | F106L | 0.993 |
| 22:39887433:A:G | F106L | 0.993 |
| 22:39887507:A:T | L81H | 0.993 |
| 22:39887544:G:T | R69S | 0.993 |
| 22:39887569:T:A | R60S | 0.993 |
| 22:39887569:T:G | R60S | 0.993 |
| 22:39887687:A:T | V21D | 0.993 |
| 22:39887673:A:G | S26P | 0.992 |
| 22:39887525:A:T | L75H | 0.990 |
| 22:39887529:A:G | S74P | 0.990 |
dbSNP variants (sampled 300 via entrez): RS1000028149 (22:39758149 G>A), RS1000028201 (22:39855308 C>G), RS1000041339 (22:39750637 T>G), RS1000055651 (22:39847940 G>A), RS1000068936 (22:39859763 A>C), RS1000102681 (22:39756487 C>A), RS1000134048 (22:39857688 T>C), RS1000171593 (22:39755626 C>T), RS1000185422 (22:39854995 A>G), RS1000190568 (22:39800049 T>C), RS1000199757 (22:39852696 A>G), RS1000230604 (22:39814060 A>G), RS1000256161 (22:39862210 G>A), RS1000258677 (22:39815357 C>A,G,T), RS1000298017 (22:39793838 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
6 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005752_107 | Systemic lupus erythematosus | 5.000000e-08 |
| GCST005951_24 | Body mass index | 2.000000e-08 |
| GCST009391_1758 | Metabolite levels | 1.000000e-06 |
| GCST009597_201 | Multiple sclerosis | 1.000000e-08 |
| GCST009600_9 | Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) | 7.000000e-11 |
| GCST90002382_511 | Eosinophil percentage of white cells | 3.000000e-09 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
| EFO:0010370 | lysophosphatidylethanolamine 20:4 measurement |
| EFO:0007991 | eosinophil percentage of leukocytes |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aflatoxin B2 | decreases methylation | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Valproic Acid | decreases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Antirheumatic Agents | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.